跳至主要内容
临床试验/JPRN-jRCT1080224132
JPRN-jRCT1080224132招募中Unknown

CEDARCURE SLIT-tablet special drug use surveillance

TORII Pharmaceutical CO.,LTD.0 个研究点目标入组 500 人开始时间: 2018年11月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Patients with Japanese cedar pollinosis who are diagnosed as having appropriate treatment with CEDARCURE

排除标准

  • 1)Patients who have administrated CEDARTOLEN or CEDARCURE in the past
  • 2)Patients contraindicated for CEDARCURE
  • Patients who have gone into shock after administration of CEDARCURE
  • Patients with severe asthma (Administration of CEDARCURE may induce asthmatic attacks)

研究者

相似试验